Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Actas Dermo-Sifiliográficas |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0001731023008189 |